Anderson Raymond bought MNPR
August 25, 2026 · Form 4 insider transaction
Anderson Raymond bought 1,402 shares of Monopar Therapeutics Inc. at $30.00 per share, a transaction worth $42.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,402
Price
$30.00
Total value
$42.1K
InsiderAnderson Raymond
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 25, 2026
Filing dateAugust 28, 2026
Shares owned after6,775
OwnershipDirect
10b5-1 planYes
AmendedYes
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026.